Enter your search term above.

Women and lung cancer

Together, we can end lung cancer for good.

Our mission is to increase lung cancer awareness and support the research that will help eradicate it, in our sisters, in our moms, in our daughters, and in us.

Join the fight, and get involved! Your support will help us to find an end to lung cancer.

#TogetherSeparately: Women & Lung Cancer

This webinar on May 10 will cover risk factors, actionable prevention, and early detection steps to improve outcomes for women who are diagnosed with lung cancer. We will also discuss women’s sexuality and sexual health as it relates to the lung cancer journey – an important but often overlooked topic.

Want to know more?


  • Worldwide, over 600,000 women die of lung cancer each year.
  • 1 in 17 women will develop lung cancer over their lifetime.
  • While lung cancer diagnoses have been leveling off or declining, they are doing so for women at a slower pace than for men.
  • Lung adenocarcinoma is the most common type of lung cancer found in women (and men) in the US.
  • Lung cancer kills one and a half times as many women as breast cancer.
  • While smoking represents the number one risk factor for developing lung cancer, 20% of lung cancer diagnoses occur in non-smokers. But research is showing that women may have more risk factors even when controlling for smoking history, compared to men.
  • Non-smokers who develop lung cancer are nearly twice as likely to be women than men.
  • In 2023, an estimated 59,910 women will die of lung cancer in the US.
  • In 2023, nearly 121,000 American women will be diagnosed with lung cancer.

Chart: Estimated number of cancer deaths among women in 2023

Interested in hearing the latest on lung cancer research?

Sign up for our newsletter!

From our news page: women in lung cancer

Women’s Stories of Hope

Show your support and share the facts by tweeting with the hashtag #WomenLC.

This program is made possible by the generous support of Bristol Myers-Squibb and Genentech, a member of the Roche Group.